Viewing Study NCT06790602


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2025-12-26 @ 2:55 AM
Study NCT ID: NCT06790602
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-04
First Post: 2025-01-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Sponsor: University of California, San Diego
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module